IBAB - Ion Beam Applications SA (ENXTBR) - Share Price and News

Ion Beam Applications SA
BE ˙ ENXTBR ˙ BE0003766806
11,80 € ↑0.22 (1.90%)
2025-09-05
SHARE PRICE
Overview
Ion Beam Applications S.A. (IBA) is a global medical technology company based in Belgium. The company operates in the healthcare sector, providing solutions for the diagnosis and treatment of cancer. IBA is a leader in proton therapy, a type of radiation treatment that uses protons to treat cancer. Some of their key projects include the Proteus®ONE and Proteus®PLUS, compact and comprehensive proton therapy solutions.
AI+ Ask Fintel’s AI assistant about Ion Beam Applications SA.
Thinking about good questions…
Basic Stats

The share price of Ion Beam Applications SA as of 5 September 2025 is 11,80 € / share. This is a decrease of -1.34% from the prior week.

The Factor Analysis chart (below right) shows a view of Ion Beam Applications SA from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap
EV
Shares Out. 0.00 MM
Earnings Date
EPS (TTM)
Dividend Yield 2.07 %
Ex-Dividend Date 2025-06-18
Borrow Rate 2.19
Short Shares Avail. 0.06 MM
Short Interest
Short Float
Days to Cover
Risk Free Rate 4.17 %
Price Change (1 yr) 3.76 %
Volatility (1 yr) 0.37
Beta 0.77
Sharpe Ratio (1 yr) -0.01
Sortino Ratio (1 yr) -0.02
PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV
ROA 0.03
ROE 0.19
ROIC 0.09
CROIC -0.13
OCROIC 0.02
Implied Volatility
Put/Call OI Ratio
Growth 87.78 /100
Profitability 39.18 /100
Quality Score 21.07 /100
Value Score
Momentum Score 29.40 /100
Stability (Low Vol) Score 60.06 /100
Analyst Sentiment 66.35 /100
Fund Sentiment 87.12 /100
Insider Sentiment
Officer Sentiment
Dividend Score 49.04 /100
QVM Score
Piotroski F-SCORE 5.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target

The average one-year price target for Ion Beam Applications SA is 15,81 €. The forecasts range from a low of 12,12 € to a high of 18,90 €. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-09-02 2026-09-02 18.90 12.12 16.32 15.81
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Ion Beam Applications SA. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2023-03-23 KBC SECURITIES Hold Buy Upgrade
2022-07-13 ING FM Sell Hold Upgrade
2022-01-20 KBC SECURITIES Hold Hold Maintains
2021-10-27 ING FM Sell Sell Maintains
2023-05-21 DEGROOF PETERCAM Buy Buy Maintains
2023-05-16 KBC SECURITIES Hold Buy Upgrade
2022-07-12 ING FM Sell Hold Upgrade
2022-01-19 KBC SECURITIES Hold Hold Maintains
2021-10-26 ING FM Sell Sell Maintains
2023-08-30 DEGROOF PETERCAM Buy Buy Maintains
2023-08-30 KBC SECURITIES Buy Buy Maintains
2023-12-21 DEGROOF PETERCAM Buy Buy Maintains
2023-12-21 KBC SECURITIES Buy Buy Maintains
2023-08-31 DEGROOF PETERCAM Buy Buy Maintains
2023-08-31 KBC SECURITIES Buy Buy Maintains
2023-05-22 DEGROOF PETERCAM Buy Buy Maintains
2023-05-17 KBC SECURITIES Hold Buy Upgrade
2024-05-28 ING FM Hold Hold Maintains
2024-05-22 DEGROOF PETERCAM Buy Buy Maintains
2024-05-01 KBC SECURITIES Buy Buy Maintains
2023-12-20 DEGROOF PETERCAM Buy Buy Maintains
2023-12-20 KBC SECURITIES Buy Buy Maintains
2025-04-07 KBC SECURITIES Buy Buy Maintains
2025-03-19 DEGROOF PETERCAM Buy Buy Maintains
2025-02-25 ING FM Hold Hold Maintains
2024-11-26 ING FM Hold Hold Maintains
2024-11-20 DEGROOF PETERCAM Buy Buy Maintains
2024-11-17 KBC SECURITIES Buy Buy Maintains
2025-06-02 DEGROOF PETERCAM Buy Buy Maintains
2025-05-27 ING FM Hold Hold Maintains
2025-05-21 KBC SECURITIES Buy Buy Maintains
Other Listings
US:IOBCF
GB:IBABB
GB:0GZK 11,97 €
DE:IOB
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista